BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22114858)

  • 1. Immune-modulating interventions in critically ill septic patients: pharmacological options.
    Toft P; Tønnesen E
    Expert Rev Clin Pharmacol; 2011 Jul; 4(4):491-501. PubMed ID: 22114858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cortisol in critically ill patients with sepsis--physiological functions and therapeutic implications].
    Briegel J
    Wien Klin Wochenschr; 2002; 114 Suppl 1():9-19. PubMed ID: 15503552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin replacement in patients with sepsis and septic shock.
    Giudici D; Baudo F; Palareti G; Ravizza A; Ridolfi L; D' Angelo A
    Haematologica; 1999 May; 84(5):452-60. PubMed ID: 10329925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New concepts in treatment of sepsis.
    le Roux P
    SADJ; 2004 Jun; 59(5):208-9. PubMed ID: 15449442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators.
    Orfanos SE; Kotanidou A; Glynos C; Athanasiou C; Tsigkos S; Dimopoulou I; Sotiropoulou C; Zakynthinos S; Armaganidis A; Papapetropoulos A; Roussos C
    Crit Care Med; 2007 Jan; 35(1):199-206. PubMed ID: 17110873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sepsis in the critically-ill patient].
    Christensen VB; Nielsen JS; Tønnesen EK
    Ugeskr Laeger; 2007 Feb; 169(8):703-5. PubMed ID: 17313921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The current management of septic shock.
    Russel JA
    Minerva Med; 2008 Oct; 99(5):431-58. PubMed ID: 18971911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathophysiology of sepsis and possible influence of statins].
    Fraunberger P; Drexel H; Walli AK
    Dtsch Med Wochenschr; 2010 Oct; 135(43):2128-32. PubMed ID: 20960384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects and mechanisms of insulin on systemic inflammatory response and immune cells in severe trauma, burn injury, and sepsis.
    Deng HP; Chai JK
    Int Immunopharmacol; 2009 Oct; 9(11):1251-9. PubMed ID: 19647101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on the pathophysiology of sepsis.
    le Roux P
    SADJ; 2004 May; 59(4):163, 165. PubMed ID: 15279093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock.
    Varghese JM; Roberts JA; Lipman J
    Crit Care Clin; 2011 Jan; 27(1):19-34. PubMed ID: 21144984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory therapy for sepsis: an update.
    Christaki E; Anyfanti P; Opal SM
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1013-33. PubMed ID: 22029521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipids in critical care medicine.
    Ott J; Hiesgen C; Mayer K
    Prostaglandins Leukot Essent Fatty Acids; 2011 Nov; 85(5):267-73. PubMed ID: 21546231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current advances in sepsis and septic shock with particular emphasis on the role of insulin.
    Das UN
    Med Sci Monit; 2003 Aug; 9(8):RA181-92. PubMed ID: 12942044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Septic shock: new pharmacotherapy options or better trial design?
    Vincent JL; Van Nuffelen M
    Expert Opin Pharmacother; 2013 Apr; 14(5):561-70. PubMed ID: 23452102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediator-specific therapies for the systemic inflammatory response syndrome, sepsis, severe sepsis, and septic shock: present and future approaches.
    Hazinski MF
    Crit Care Nurs Clin North Am; 1994 Jun; 6(2):309-19. PubMed ID: 7946190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New perspectives on immunomodulatory therapy for bacteraemia and sepsis.
    Opal SM
    Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S70-3. PubMed ID: 21129935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why have clinical trials in sepsis failed?
    Marshall JC
    Trends Mol Med; 2014 Apr; 20(4):195-203. PubMed ID: 24581450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacotherapy of sepsis].
    Guzzo I; Morabito S; Stucchi R; Poli G; Fumagalli R
    G Ital Nefrol; 2006; 23 Suppl 36():S79-86. PubMed ID: 17068734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Critical analysis of noninflammatory treatments of sepsis: lessons learned from previous trials].
    Montravers P; Lasocki S; Seguin P; Malledant Y
    Ann Fr Anesth Reanim; 2007 Apr; 26(4):363-9. PubMed ID: 17336486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.